Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose CHF 5188 vs Symbicort vs placebo in adults with moderate or severe persistent asthma
2008-001773-15Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CHF 5188 in asthma and severe asthma (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Through FEV1 (mean 23h-24h FEV1). Started Jul 2008; status: completed.
02
Drugs
CHF 5188
03
Conditions
asthmasevere asthma
Beyond the preview
Go deeper on 2008-001773-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001773-15.